ArticleOncotarget2017
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.
Iva Gudernova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleOncotarget2017
Iva Gudernova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.